5例原发性皮肤CD30阳性淋巴组织增生性疾病临床病理分析.docVIP

5例原发性皮肤CD30阳性淋巴组织增生性疾病临床病理分析.doc

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
5例原发性皮肤CD30阳性淋巴组织增生性疾病临床病理分析   【摘要】 目的:探究皮肤CD30阳性淋巴组织增生性疾病的临床病理特点。方法:选取2008年2月-2009年8月本院收治的5例皮肤CD30阳性淋巴组织增生性疾病患者,包括2例淋巴瘤样丘疹病和3例原发性皮肤CD30+间变性大细胞淋巴瘤,收集其临床治疗及随访资料,并进行回顾性分析,着重比较各型CD30阳性淋巴组织增生性疾病的病理及临床特点。结果:2例淋巴瘤样丘疹病的发病年龄分别是28岁和62岁,临床特点为反复发作的结节性皮肤样丘疹,随访生存率为100%;3例原发性皮肤CD30+间变性大细胞淋巴瘤患者发病年龄分别为7岁、54岁、70岁,临床特点为结节肿块伴有溃疡形成,随访生存率81.0%。结论:CD30阳性淋巴组织增生性疾病的临床表现多样,不同疾病及分型的病理表现、临床治疗、预后均不同,在临床确诊时需做好鉴别诊断,明确疾病分型,以进行有针对性的治疗。   【关键词】 皮肤; CD30阳性; 淋巴组织增生性疾病   Clinical Pathological Analysis of 5 Cases of Primary Cutaneous CD30 Positive Lymphoproliferative Disease/FENG Xiao-jie,YANG Qian.//Medical Innovation of China,2014,11(01):060-062   【Abstract】 Objective:To investigate the clinic pathologic features of primary cutaneous CD30+ lymphoproliferative disease.Method:A total of 5 patients that had primary cutaneous CD30+ lymphoproliferative disease including 3 cases of CALCL and 2 cases of LyP from February 2008 to August 2009 in our hospital were selected as the research objects.Clinical treatment and follow-up data were summarized and clinic pathologic features was emphasized.Result:Among 5 cases,2 cases were lymphomatoid papulosis(LyP),the age of onset of 2 cases of lymphomatoid papulosis was respectively 28 and 62 years old and presented multiple recurrent,self-healing skin papules,the survival rate was 100%.Among 5 cases,3 cases were primary cutaneous anaplastic large-cell lymphomas (C-ALCL),7,54,70 years old respectively and presented nodules,masses and plaques,sometimes with ulceration,and the survival rate was 100%.Conclusion:The clinical manifestations of CD30+ lymphoproliferative disease are various different diseases,pathological presentation of different diseases and parting,clinical treatment and prognosis are different.It needs to make the differential diagnosis and explicit the classification of disease in clinical diagnosis for targeted treatment.   【Key words】 Skin; CD30+; Lymphoproliferative disease   First-author’s address:The First People’s Hospital of Kunming Cit

文档评论(0)

lmother_lt + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档